Pozen, Xcel MT 300 marketing deal

POZN granted Xcel (San Diego, Calif.) exclusive U.S. rights to market POZN's MT 300 injectable dihydroergotamine mesylate

Read the full 175 word article

How to gain access

Continue reading with a
two-week free trial.